Vimarsana
Biggest News Aggregation in the World

Mariat Abreu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mariat Abreu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mariat Abreu Today - Breaking & Trending Today

A catered low-fat, high-fiber diet 'new, hopeful option' to manage Crohn's disease - Vimarsana News

A catered low-fat, high-fiber diet 'new, hopeful option' to manage Crohn's disease

WASHINGTON — Patients with Crohn’s disease who ate a catered low-fat, high-fiber diet for 8 weeks experienced improvements in symptoms, inflammation and quality of life vs. those offered counseling alone, researchers reported. “We know that most patients with Crohn’s disease seek dietary counseling and ask their physicians about the foods they should consume,” Hajar

Source: healio.com
A Close Look at the Data Backing Upadacitinib's Approval in Crohn's - Vimarsana News

A Close Look at the Data Backing Upadacitinib's Approval in Crohn's

Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response

Scrubs & Heels roundup: Branding, leadership, empowerment - Vimarsana News

Scrubs & Heels roundup: Branding, leadership, empowerment

Healio presents some of the top stories from the inaugural Scrubs & Heels Summit 2022 in Miami, which highlight social media branding, female empowerment in GI, lessons for negotiation and leadership, and more.

Source: healio.com
Female physicians can change the landscape by caring for themselves, other women - Vimarsana News

Female physicians can change the landscape by caring for themselves, other women

MIAMI — Women in gastroenterology should know what they bring to an institution and to a practice, quantifying their worth and furthering the path for other women to join the field, a presenter at Scrubs & Heels Summit 2022 said. “It’s not just equal pay. ... It’s knowing your return on investment, the big picture, the value of attracting more patients. We need to sell

Source: healio.com
FDA Approves Upadacitinib for Ulcerative Colitis - Vimarsana News

FDA Approves Upadacitinib for Ulcerative Colitis

Upadacitinib has been shown to rapidly control symptoms in adults with moderate to severe active ulcerative colitis. It’s the first FDA approval for the JAK inhibitor in gastroenterology.